康方生物跌超6%，报94.75港元。康方生物公布截至6月底止中期业绩，股东应占亏损4.24亿元，去年同期亏损5.7亿元，每股亏损46分，不派息。期内，总收入18.06亿元，同比增27.92%；毛利13.4亿元，上升19.6%。
康方生物跌超6%，报94.75港元。康方生物公布截至6月底止中期业绩，股东应占亏损4.24亿元，去年同期亏损5.7亿元，每股亏损46分，不派息。期内，总收入18.06亿元，同比增27.92%；毛利13.4亿元，上升19.6%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.